Skip to main content

Table 4 Number of children with adverse events

From: The antipyretic efficacy and safety of propacetamol compared with dexibuprofen in febrile children: a multicenter, randomized, double-blind, comparative, phase 3 clinical trial

  Study group (n = 125) Control group (n = 138) p-value
Vomiting 1 (0.8) 4 (2.9) 0.373
Diarrhea 3 (2.4) 7 (5.1) 0.340
Abdominal pain 0 (0) 1 (0.7)
Constipation 1 (0.8) 0 (0)
Rash 5 (4.0) 5 (3.6)
Elevated liver enzyme level
 AST 8 (6.4) 14 (10.1) 0.373
 ALT 5 (4.0) 9 (6.5) 0.420
Thrombocytopenia 8 (6.4) 13 (9.4) 0.495
  1. Results are presented as a percentage (%)
  2. AST aspartate aminotransferase
  3. ALT alanine aminotransferase